BioSpace News Archive

Bone Therapeutics SA : Provides Business Outlook and Announces Its Financial Calendar for 2018

The Company started 2018 with EUR 8.4 million in cash.

January 23, 2018
·
5 min read
Biotech Bay

Portola Pharmaceuticals Announces Acceptance of Late-Breaker Abstract Highlighting New Data for Andexanet Alfa at ACC.18

The data will be presented on Monday, March 12, 2018 at 11:30 a.m. ET.

January 23, 2018
·
4 min read
Drug Development

ChemoCentryx Surges on Early-Stage Pancreatic Cancer Trial Data

The study demonstrated OS of 29% at 18 months with CCX872 and FOLFIRINOX combination therapy in all patients treated.

January 23, 2018
·
7 min read
Biotech Bay

Ultragenyx Announces Proposed Public Offering of Common Stock

The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed.

January 23, 2018
·
4 min read
Genetown

BeiGene Announces Closing of $800M Public Offering

BeiGene intends to use proceeds from the offering for working capital and general corporate purposes, including research and development activities.

January 23, 2018
·
3 min read
Business

TLC and Jixi Biotechnology Partners Announce Joint Venture

The new partnership’s efforts will take place pursuant to recent reforms by the CFDA, which include initiatives designed to accelerate drug approvals and encourage innovation, including greater alignment of China’s review process with that of the US and the EU.

January 23, 2018
·
3 min read
Profounda Launches Rhinase Baby Lubricating Nasal Drops

Profounda announced today that Rhinase Baby Lubricating Nasal Drops is now available in the United States through Rhinase.com and Amazon.com as well as on retail shelves at Kinney Drugs. Patients can also ask their Pharmacists to order Rhinase products directly from Profounda or Cardinal Health.

January 23, 2018
·
2 min read
Pharm Country

Insmed Announces Proposed Public Offering of Convertible Senior Notes

The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

January 23, 2018
·
9 min read
The National University of Science and Technology MISiS Scientists Synthesize Nanoparticle-Antioxidants to Treat Strokes and Spinal Cord Injuries

An international science team has developed an innovative therapeutic complex based on multi-layer polymer nano-structures of superoxide dismutase.

January 23, 2018
·
3 min read
Business

TechCare Signs its First European Distribution Agreement for Novokid Lice Treatment Device, With MWMedical B.V. in the Netherlands

The multi-year agreement grants the distributor exclusive distribution rights in the Netherlands in consideration of minimum purchase commitments.

January 23, 2018
·
6 min read